2020 starts well: first hospitals use DeltaScan in routine care
Utrecht, 2 jan 2020
Thirteen hospital departments from the Netherlands, Germany and Belgium are participating in CLEO (CLinical Evaluation Of DeltaScan). This international Clinical Evaluation Program is led by UMC Utrecht (Prof. Dr. Slooter), together with consortium Partners Charité (Prof. Dr. Spies) and KU Leuven (Prof. Dr. Milisen).
In 2019 CLEO started already. All staff (nurses and physicians) from the participating departments made a.o. delirium e-learnings, did delirium protocol checks and got a delirium checklist/protocol refreshment course. Then they enrolled in the control phase, in which the usual delirium checklists were continued to be used for detection and monitoring of all patients at risk of delirium.
Now, in January 2020 the first departments enrolled in the exciting intervention phase of CLEO. In this phase, they will use DeltaScan in stead of checklists.
Prior to entering the intervention phase, the staff made the e-learning DeltaScan / delirium, and superusers were trained to use the DeltaScan. UMC Utrecht research nurses and Prolira’s clinical application specialists were onsite as much as they could, to support the departments with the implementation.
In the next months of 2020, new pairs of departments will switch to the use of DeltaScan (the intervention phase of CLEO).
UMC Utrecht Cardiothoracic surgery department and Isala ICU started the intervention phase in January!
Back to all news items
3584 CH Utrecht
tel: +31 (0)6 2297 8972